ASCO Reading Room | Nicholas Short, MD, on Intensive Chemotherapy in Older Patients With AML

Evidence suggests newer less-intensive options have better outcomes

Related Keywords

Houston ,Texas ,United States ,Massachusetts ,Hagop Kantarjian ,Astellas Pharma ,Amgen ,Astrazeneca ,University Of Texas Md Anderson Cancer Center ,Jazz Pharmaceuticals ,Novartis ,Nicholas Short ,Cancer Center ,Massachusetts General Hospital ,Clin Oncol ,